Mylan announced the launch of Metoprolol Tartrate Tablets in new 37.5mg and 75mg strengths, the generic version of Novartis‘ Lopressor

Metoprolol Tartrate is a cardioselective beta-blocker indicated for the long-term management of angina, in stabilized patients after MI to reduce mortality, and for the treatment of hypertension. Clinical pharmacology studies have demonstrated the beta-blocking activity of metoprolol, as shown by: reduction in heart rate and cardiac output at rest and upon exercise, reduction of systolic blood pressure upon exercise, inhibition of isoproterenol-induced tachycardia, and reduction of reflex orthostatic tachycardia.

Mylan’s Metoprolol Tartrate is already available in 25mg, 50mg, and 100mg strength tablets. The 37.5mg and 75mg are the first intermediate dosage strengths available between the existing strengths.

For more information call (800) RX-MYLAN or visit